Selective antiproliferative effect of C-2 halogenated 13α-estrones on cells expressing Organic anion-transporting

Réka Laczkó-Rigó1, Éva Bakos1, Rebeka Jójárt2

  • 1Institute of Enzymology, Research Centre for Natural Sciences, Eötvös Loránd Research Center, Magyar tudósok körútja 2, H-1117 Budapest, Hungary.

Insights

C-2 halogenated 13α-estrones selectively inhibit cancer cell growth by targeting the OATP2B1 transporter. This transporter mediates drug uptake, suggesting these compounds are promising for developing targeted anti-cancer therapies.

Area of Science:

  • Pharmacology
  • Oncology
  • Molecular Biology

Background:

  • Organic anion-transporting polypeptide 2B1 (OATP2B1) facilitates cellular uptake of steroids and drugs, and is implicated in hormone-dependent tumor progression.
  • 13α-estrones are potential inhibitors of hormone-dependent cancers by blocking estrogen formation.

Purpose of the Study:

  • To investigate the antiproliferative effects of 13α/β-estrone derivatives on OATP2B1-overexpressing cancer cells.
  • To determine if OATP2B1 mediates the cellular uptake and growth inhibitory effects of these estrone derivatives.

Main Methods:

  • Comparing the antiproliferative activity of 13α/β-estrones in control and OATP2B1-overexpressing A431 carcinoma cells.
  • Synthesizing tritium-labeled 2-bromo-13α-estrone for direct transport assays.
  • Measuring the accumulation of [3H]2-bromo-13α-estrone in cells to confirm OATP2B1-mediated uptake.

Main Results:

  • 3-O-benzyl 13α/β-estrones showed increased antiproliferative effects in both cell types.
  • C-2 halogenated 13α-estrones demonstrated selective OATP2B1-mediated growth inhibition.
  • [3H]2-bromo-13α-estrone accumulation was significantly increased in OATP2B1-overexpressing cells, confirming OATP2B1-mediated uptake.

Conclusions:

  • C-2 halogenated 13α-estrones exhibit selective anti-cancer activity by leveraging OATP2B1-mediated uptake.
  • These compounds represent promising candidates for designing novel anti-cancer drugs targeting OATP2B1.

Related Concept Videos

Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
658
Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
3.0K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
15.4K
Pore Transport and Ion-Pair Transport01:17

Pore Transport and Ion-Pair Transport

Pore transport and ion-pair formation are critical mechanisms for the absorption and distribution of drugs in the body.
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited  but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct...
778
Hepatic Drug Clearance: Role of Transporters01:14

Hepatic Drug Clearance: Role of Transporters

In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
143
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K